SCHEMBL23578969

SCHEMBL23578969

CO[C@H]1CCN(C(=O)OC(C)(C)C)CC1(F)F

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 1/20 0.44
▸ RECQL P46063 1/20 0.43
▸ EPHX1 P07099 1/20 0.43
▸ EPHX2 P34913 1/20 0.41
▸ USP2 O75604 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ GPR119 Q8TDV5 4/20 0.40
▸ STS P08842 2/20 0.40
▸ HSD17B10 Q99714 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ PTPN2 P17706 1/20 0.39
▸ PTPN1 P18031 1/20 0.39
▸ PTPN6 P29350 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23817330 1.00 HPGD (0.44) HPGDRECQLEPHX1EPHX2USP2
SCHEMBL21111211 1.00 HPGD (0.44) HPGDRECQLEPHX1EPHX2USP2
SCHEMBL23578918 0.87 HPGD (0.43) HPGDRECQLEPHX1EPHX2USP2
SCHEMBL14671917 0.85 HPGD (0.47) HPGDRECQLEPHX1EPHX2USP2
SCHEMBL14671914 0.85 HPGD (0.47) HPGDRECQLEPHX1EPHX2USP2
SCHEMBL15105073 0.85 HPGD (0.47) HPGDRECQLEPHX1EPHX2USP2
SCHEMBL20709187 0.85 HPGD (0.42) HPGDRECQLEPHX1EPHX2USP2
SCHEMBL26630212 0.82 STS (0.40) HPGDRECQLEPHX1EPHX2GPR119
SCHEMBL23579228 0.82 HPGD (0.44) HPGDRECQLEPHX1EPHX2USP2
SCHEMBL29958797 0.82 HPGD (0.44) HPGDRECQLEPHX1EPHX2USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081515-A1 INHIBITORS OF MUTANT FORMS OF EGFR Blueprint Medicines Corporation (US) 2022-11-02 — — EP disclosed
WO-2021133809-A1 INHIBITORS OF MUTANT FORMS OF EGFR BLUEPRINT MEDICINES CORPORATION (US) 2021-07-01 — — WO disclosed
Send feedback